209 related articles for article (PubMed ID: 31013940)
1. Mining for Oxysterols in
Meljon A; Crick PJ; Yutuc E; Yau JL; Seckl JR; Theofilopoulos S; Arenas E; Wang Y; Griffiths WJ
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013940
[TBL] [Abstract][Full Text] [Related]
2. Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.
Schöls L; Rattay TW; Martus P; Meisner C; Baets J; Fischer I; Jägle C; Fraidakis MJ; Martinuzzi A; Saute JA; Scarlato M; Antenora A; Stendel C; Höflinger P; Lourenco CM; Abreu L; Smets K; Paucar M; Deconinck T; Bis DM; Wiethoff S; Bauer P; Arnoldi A; Marques W; Jardim LB; Hauser S; Criscuolo C; Filla A; Züchner S; Bassi MT; Klopstock T; De Jonghe P; Björkhem I; Schüle R
Brain; 2017 Dec; 140(12):3112-3127. PubMed ID: 29126212
[TBL] [Abstract][Full Text] [Related]
3. Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.
Marelli C; Lamari F; Rainteau D; Lafourcade A; Banneau G; Humbert L; Monin ML; Petit E; Debs R; Castelnovo G; Ollagnon E; Lavie J; Pilliod J; Coupry I; Babin PJ; Guissart C; Benyounes I; Ullmann U; Lesca G; Thauvin-Robinet C; Labauge P; Odent S; Ewenczyk C; Wolf C; Stevanin G; Hajage D; Durr A; Goizet C; Mochel F
Brain; 2018 Jan; 141(1):72-84. PubMed ID: 29228183
[TBL] [Abstract][Full Text] [Related]
4. SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment.
Mignarri A; Carecchio M; Del Puppo M; Magistrelli L; Di Bella D; Monti L; Dotti MT
J Neurol Sci; 2017 Dec; 383():39-41. PubMed ID: 29246618
[No Abstract] [Full Text] [Related]
5. SPG5 and multiple sclerosis: clinical and genetic overlap?
Criscuolo C; Carbone R; Lieto M; Peluso S; Guacci A; Filla A; Quarantelli M; Lanzillo R; Morra VB; De Michele G
Acta Neurol Scand; 2016 Jun; 133(6):410-4. PubMed ID: 26370385
[TBL] [Abstract][Full Text] [Related]
6. 24S,25-Epoxycholesterol in mouse and rat brain.
Wang Y; Karu K; Meljon A; Turton J; Yau JL; Seckl JR; Wang Y; Griffiths WJ
Biochem Biophys Res Commun; 2014 Jun; 449(2):229-34. PubMed ID: 24832732
[TBL] [Abstract][Full Text] [Related]
7. Exome Sequencing Reveals a Novel Homozygous Frameshift Mutation in the CYP7B1 Gene in a Japanese Patient with SPG5.
Nan H; Shimozono K; Ichinose Y; Tsuchiya M; Koh K; Hiraide M; Takiyama Y
Intern Med; 2019 Mar; 58(5):719-722. PubMed ID: 30333426
[TBL] [Abstract][Full Text] [Related]
8. Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis.
Schüle R; Siddique T; Deng HX; Yang Y; Donkervoort S; Hansson M; Madrid RE; Siddique N; Schöls L; Björkhem I
J Lipid Res; 2010 Apr; 51(4):819-23. PubMed ID: 19812052
[TBL] [Abstract][Full Text] [Related]
9. Comparative modeling of 25-hydroxycholesterol-7α-hydroxylase (CYP7B1): ligand binding and analysis of hereditary spastic paraplegia type 5 CYP7B1 mutations.
Siam A; Brancale A; Simons C
J Mol Model; 2012 Feb; 18(2):441-53. PubMed ID: 21541746
[TBL] [Abstract][Full Text] [Related]
10. On the regulatory importance of 27-hydroxycholesterol in mouse liver.
Heverin M; Ali Z; Olin M; Tillander V; Joibari MM; Makoveichuk E; Leitersdorf E; Warner M; Olivercrona G; Gustafsson JÅ; Björkhem I
J Steroid Biochem Mol Biol; 2017 May; 169():10-21. PubMed ID: 26851362
[TBL] [Abstract][Full Text] [Related]
11. CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5.
Goizet C; Boukhris A; Durr A; Beetz C; Truchetto J; Tesson C; Tsaousidou M; Forlani S; Guyant-Maréchal L; Fontaine B; Guimarães J; Isidor B; Chazouillères O; Wendum D; Grid D; Chevy F; Chinnery PF; Coutinho P; Azulay JP; Feki I; Mochel F; Wolf C; Mhiri C; Crosby A; Brice A; Stevanin G
Brain; 2009 Jun; 132(Pt 6):1589-600. PubMed ID: 19439420
[TBL] [Abstract][Full Text] [Related]
12. Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis.
Raselli T; Hearn T; Wyss A; Atrott K; Peter A; Frey-Wagner I; Spalinger MR; Maggio EM; Sailer AW; Schmitt J; Schreiner P; Moncsek A; Mertens J; Scharl M; Griffiths WJ; Bueter M; Geier A; Rogler G; Wang Y; Misselwitz B
J Lipid Res; 2019 Jul; 60(7):1270-1283. PubMed ID: 31113816
[TBL] [Abstract][Full Text] [Related]
13. Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse.
Meljon A; Wang Y; Griffiths WJ
Biochem Biophys Res Commun; 2014 Apr; 446(3):768-74. PubMed ID: 24491562
[TBL] [Abstract][Full Text] [Related]
14. Elevated hydroxycholesterols in Norwegian patients with hereditary spastic paraplegia SPG5.
Prestsæter S; Koht J; Lamari F; Tallaksen CME; Hoven STJ; Vigeland MD; Selmer KK; Rydning SL
J Neurol Sci; 2020 Dec; 419():117211. PubMed ID: 33160247
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of Taiwanese patients with Hereditary spastic paraplegia type 5.
Chou CT; Soong BW; Lin KP; Tsai YS; Jih KY; Liao YC; Lee YC
Ann Clin Transl Neurol; 2020 Apr; 7(4):486-496. PubMed ID: 32202070
[TBL] [Abstract][Full Text] [Related]
16. Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1-/- mouse brain and plasma.
Griffiths WJ; Crick PJ; Meljon A; Theofilopoulos S; Abdel-Khalik J; Yutuc E; Parker JE; Kelly DE; Kelly SL; Arenas E; Wang Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Feb; 1864(2):191-211. PubMed ID: 30471425
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
[TBL] [Abstract][Full Text] [Related]
19. Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations.
Arnoldi A; Crimella C; Tenderini E; Martinuzzi A; D'Angelo MG; Musumeci O; Toscano A; Scarlato M; Fantin M; Bresolin N; Bassi MT
Clin Genet; 2012 Feb; 81(2):150-7. PubMed ID: 21214876
[TBL] [Abstract][Full Text] [Related]
20. Hereditary spastic paraparesis due to SPG5/CYP7B1 mutation with potential therapeutic implications.
Pérez-Torre P; García Galloway E; López-Sendón Moreno JL
Neurologia (Engl Ed); 2023; 38(9):710-711. PubMed ID: 37858890
[No Abstract] [Full Text] [Related]
[Next] [New Search]